MetaCap

Accuray Incorporated (ARAY)

NASDAQ: ARAYHealth CareMedical/Dental InstrumentsUSD

2.08-0.045 (-2.12%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ARAY stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$5.60
52-week range
2.05 – 45.20
Day range
2.06 – 2.19
Volume / Avg
111.53K / 201.35K
Beta
—

52-week range

$2.05$45.20

ARAY stock today

Shares of Accuray (ARAY) finished lower on Nov 20 at $2.08, a drop of 2.12% or $0.045 per share, versus the S&P 500's 3.70% decline. Shares are 95.4% below their 52-week high of $45.20 and 1.2% above the 52-week low of $2.05, near the bottom of the past year's range. ARAY is up 153.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 97.6%.

Accuray has posted a net loss over the last twelve months (EPS of -$5.60), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Accuray

Company profile

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.

Industry
Medical/Dental Instruments
CEO
Mr. Stephen R. LaNeve MBA
Headquarters
Madison, WI
Employees
809
IPO year
2007

Financial highlights

Full financials

In fiscal 2026, Accuray generated $401.9 million in revenue, down 12.3% from fiscal 2025, its first annual decline since 2024. Accuray reported a net loss of $49.2 million, compared with a loss of $1.6 million a year earlier. Gross margin was 27.7% (down from 32.1%) and operating margin -6.6%.

Accuray annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$401.95M$458.50M$446.55M$447.61M$429.91M
Growth-12.34%+2.68%-0.24%+4.12%+8.48%
Net income$-49.19M$-1.59M$-15.54M$-9.28M$-5.35M
EPS (diluted)—$-0.02$-0.16$-0.10$-0.06

Analyst forecast

Forecast

Consensus (1 analysts)

none

  • Strong buy 0
  • Buy 0
  • Hold 1
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$-0.18 vs —

ARAY news

All ARAY news

Accuray peers

Health Care sector
ARAY peer companies
CompanyPrice% ChgMarket capCompare
CNSYCerenome Inc.0.6301-10.29%$6.16Mvs ARAY
NMTCNeuroOne Medical Technologies Corporation0.6521-3.38%$5.94Mvs ARAY
BDMDBaird Medical Investment Holdings Ltd0.0897-12.91%$5.07Mvs ARAY
ICUSeaStar Medical Holding Corporation0.935-10.95%$4.97Mvs ARAY
WOKWORK Medical Technology Group LTD Class A1.10-5.13%$4.90Mvs ARAY
SKYASkyAI Inc.2.18-45.50%$7.82Mvs ARAY
INBSIntelligent Bio Solutions Inc.1.39-7.95%$4.61Mvs ARAY
ICCMIceCure Medical Ltd.0.8006-19.71%$4.45Mvs ARAY

Indexes, lists and sector

Accuray stock FAQ

What is Accuray's stock price today?

ARAY last traded at $2.08 as of Nov 20, 4:00 PM EST, down 2.12% on the day. Prices are delayed at least 15 minutes.

Does Accuray pay a dividend?

No. Accuray does not currently pay a regular cash dividend.

Who is Accuray's CEO?

Mr. Stephen R. LaNeve MBA is the chief executive officer of Accuray Incorporated, which has about 809 employees.

Has ARAY ever split its stock?

Yes. The most recent ARAY stock split was a 1-for-40 split on Nov 9, 2026.

What is the ARAY 52-week high?

The 52-week high for ARAY is $45.20 and the 52-week low is $2.05. The stock is currently 95.4% below its high.

Compare ARAY